Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;47:833-839
Published online before print April 3, 2006, doi: 10.1161/01.HYP.0000217362.34748.e0
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/5/833    most recent
01.HYP.0000217362.34748.e0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow patientINFORMation
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gangwisch, J. E.
Right arrow Articles by Malaspina, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gangwisch, J. E.
Right arrow Articles by Malaspina, D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Obesity
Right arrow Other etiology
Right arrow Epidemiology
Right arrowRelated Article

(Hypertension. 2006;47:833.)
© 2006 American Heart Association, Inc.


Original Articles

Short Sleep Duration as a Risk Factor for Hypertension

Analyses of the First National Health and Nutrition Examination Survey

James E. Gangwisch; Steven B. Heymsfield; Bernadette Boden-Albala; Ruud M. Buijs; Felix Kreier; Thomas G. Pickering; Andrew G. Rundle; Gary K. Zammit; Dolores Malaspina

From the Department of Epidemiology, Mailman School of Public Health (J.E.G., A.G.R.), and Departments of Neurology and Sociomedical Sciences (B.B-A.), Department of Medicine, Behavioral Cardiovascular Health and Hypertension Program (T.G.P.), Department of Psychiatry and Clinilabs Sleep Disorders Institute (G.K.Z.), and Department of Psychiatry, Division of Clinical Neurobiology (D.M.), College of Physicians and Surgeons, Columbia University, New York, NY; Merck Research Laboratories (S.B.H.), Rahway, NJ; Netherlands Institute for Brain Research (R.M.B., F.K.), Amsterdam, the Netherlands; and University of Vera Cruz (R.M.B.), Xalapa, Mexico.

Correspondence to James E. Gangwisch, Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th St, Room R720E, New York, NY 10032. E-mail jeg64{at}columbia.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Depriving healthy subjects of sleep has been shown to acutely increase blood pressure and sympathetic nervous system activity. Prolonged short sleep durations could lead to hypertension through extended exposure to raised 24-hour blood pressure and heart rate, elevated sympathetic nervous system activity, and increased salt retention. Such forces could lead to structural adaptations and the entrainment of the cardiovascular system to operate at an elevated pressure equilibrium. Sleep disorders are associated with cardiovascular disease, but we are not aware of any published prospective population studies that have shown a link between short sleep duration and the incidence of hypertension in subjects without apparent sleep disorders. We assessed whether short sleep duration would increase the risk for hypertension incidence by conducting longitudinal analyses of the first National Health and Nutrition Examination Survey (n=4810) using Cox proportional hazards models and controlling for covariates. Hypertension incidence (n=647) was determined by physician diagnosis, hospital record, or cause of death over the 8- to 10-year follow-up period between 1982 and 1992. Sleep durations of ≤5 hours per night were associated with a significantly increased risk of hypertension (hazard ratio, 2.10; 95% CI, 1.58 to 2.79) in subjects between the ages of 32 and 59 years, and controlling for the potential confounding variables only partially attenuated this relationship. The increased risk continued to be significant after controlling for obesity and diabetes, which was consistent with the hypothesis that these variables would act as partial mediators. Short sleep duration could, therefore, be a significant risk factor for hypertension.


Key Words: circadian rhythm • obesity • diabetes mellitus • hypertension, essential • sleep


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The prevalence of hypertension has increased over the past decade despite improvements in awareness, treatment, and control of the disease.1 During this same time period, the average sleep duration in the United States has steadily declined and has been fueled by increased opportunities to engage in activities that compete for the time allotted to sleep.2 There is evidence to suggest that the increasing prevalence of hypertension and the decline in average sleep time are related. Sleep deprivation studies of both normotensive3,4 and hypertensive5 subjects have shown significant increases in blood pressure and sympathetic nervous system activity after nights where sleep was restricted to 3.6 to 4.5 hours. Long-term treatment with melatonin, the night hormone that promotes sleep, has been shown to reduce blood pressure in hypertensive subjects.6 Short sleep duration also has been shown to increase the risk for the incidence of myocardial infarction in women, possibly as a consequence of increased blood pressure.7

Prolonged exposure to short sleep durations could function to develop and maintain hypertension and its vascular and cardiac complications. Blood pressure and heart rate follow a diurnal pattern with the lowest values occurring during sleep. Blood pressure gradually falls with the onset of sleep and then remains low until the moment of awakening, when it promptly rises.8 While normotensive subjects sleep, their blood pressure dips by an average 10% to 20%,9 whereas in hypertensive subjects, this diurnal profile is generally preserved but at a higher level of blood pressure.10 Sleeping fewer hours per night would, therefore, function to raise average 24-hour blood pressure and heart rate. Shorter sleep durations would also result in longer exposures to elevated sympathetic nervous system activity and to waking physical and psychosocial stressors. Increased exposure to stress has been shown to promote salt appetite and suppress renal salt-fluid excretion.11 Long-term exposure to increased total 24-hour hemodynamic load associated with short sleep durations could lead to structural adaptations, such as arterial and left ventricular hypertrophic remodeling, that gradually reset the entire cardiovascular system to operate at an elevated pressure equilibrium.12

Sleep apnea has long been known to be associated with hypertension and cardiovascular disease. Obesity accounts for a significant proportion of this association, because it is highly comorbid with sleep apnea and is a significant risk factor for hypertension.13 However, we are not aware of any published prospective population studies that have shown a link between short sleep duration and the incidence of hypertension in subjects without apparent sleep disorders.

In this study, we examined the relationship between self-reported sleep duration and the diagnosis of hypertension during an 8- to 10-year follow-up period between 1982 and 1992 among subjects who participated in the epidemiologic follow-up studies of the first National Health and Nutrition Examination Survey (NHANES I).14–16 We hypothesized that prolonged short sleep duration is associated with hypertension. We theorized that obesity and diabetes act as partial mediators of this relationship, because short sleep duration is associated with obesity17,18 and the incidence of type 2 diabetes19 and because depriving healthy subjects of sleep has been shown to decrease leptin, increase ghrelin, increase appetite,20 and compromise insulin sensitivity.21 We also hypothesized that the relationship between short sleep duration and the incidence of hypertension is stronger in younger subjects than in older subjects, because stronger associations have been found in younger populations than in older populations between sleep-disordered breathing and hypertension22 and between short sleep duration and obesity.17,18


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Study Population
Subjects for this study were participants in the 1982–1984, 1986, 1987, and 1992 epidemiologic follow-up studies of the NHANES I. The baseline measures of self-reported sleep duration were taken from the 1982–1984 survey, and then hypertension incidence was determined over an 8- to 10-year period until 1992. The NHANES I survey was a probability sample of the civilian noninstitutionalized population of the United States between 1971 and 1975. The survey included a standardized medical examination and questionnaires to obtain information on the effects of clinical, environmental, and behavioral factors on health conditions. The NHANES I epidemiologic follow-up study conducted between 1982 and 1984 attempted to trace and interview NHANES I subjects, or their proxies, who were aged 25 to 74 years at baseline (n=14 407). Of all eligible subjects, 85% were successfully recontacted (n=12 220). In the 1982–1984 follow-up survey, subjects were asked, "How many hours of sleep do you usually get a night (or when you usually sleep)?" Individuals who were deceased (n=1697), who did not answer the sleep duration question (n=734), who had missing data on any of the covariates (n=149), and who had hypertension at or before the 1982–1984 survey (n=4830) were excluded from the analyses, yielding a final sample size of 4810 subjects. This study involved analyses of a publicly available data set that did not include identifying information and, therefore, met federal guidelines for exemption from institutional review board review.

Assessment of Hypertension
Individuals who had systolic blood pressure readings >140 mm Hg or diastolic readings >90 mm Hg at the time of the 1982–1984 survey or who had been diagnosed with hypertension at or before the 1982–1984 survey were excluded from the analyses. The blood pressure measurement procedures used in the NHANES I were adapted from those of the American Heart Association and Hypertension Detection and Follow-Up Program.23 Three blood pressure readings were taken at the same sitting, and readings were not taken if maximum inflation level was >160 mm Hg. Incident cases of hypertension over the 8- to 10-year follow-up period between 1982 and 1992 were determined by self-report of physician diagnosis, by hospital diagnosis, or by cause of death at the times of the 1986, 1987, or 1992 follow-up surveys.

Assessment of Covariates
The 1982–1984 questionnaire included questions on history of diabetes, age, physical activity, alcohol consumption, salt consumption, pulse rate, daytime sleepiness, depression, smoking, education, ethnicity, and gender. We measured salt consumption by adding together the subject’s responses to 2 questions asking them to estimate how frequently they use salt at the table and how often they eat salty snacks. To measure the presence of depressive symptoms, we used the standard cutoff score of 16 from a total possible score of 60 on the 20-question Center for Epidemiologic Studies Depression Scale (CES-D). Subjects who did not answer any of the CES-D questions were excluded from the analyses. A total of 183 subjects (3.8% of the sample) had missing data on ≥1 of the 20 CES-D questions. Missing values for specific CES-D questions were imputed with the mean of the questions that the subject did answer. To compute body mass index (BMI; kg/m2), we used heights from medical examinations conducted between 1971 and 1975 and actual body weights measured with scales at the 1982–1984 interviews. A total of 75 subjects (1.6% of subjects) had missing values for measured body weight, but for 70 of these subjects, we were able to substitute their measured body weight with their self-reported body weight. The measured and self-reported body weights obtained in 1982–1984 for the entire sample had a Pearson correlation coefficient of 0.975, indicating a reasonable level of accuracy for the self-reported weights.

Statistical Analyses
After preliminary univariate and bivariate analyses, we used Cox proportional hazards models to examine the effect of sleep duration on the risk of being diagnosed with hypertension over the 8- to 10-year follow-up period. The time duration to diagnosis was determined from the baseline date to the first report of hypertension. Covariates in the first adjusted multivariate model (model 2) included daytime sleepiness (never/rarely/sometimes or often/almost always), depression (yes or no), physical activity (6=high, 5, 4, 3, 2=low), alcohol consumption (0, >0 and <28, or ≥28 g/day), salt per day (continuous), current smoking status (0, 1 to 5, 6 to 10, 11 to 20, or >20 cigarettes per day), pulse rate, and gender. We chose to include the demographic variables of education (high school graduate or >high school graduate), age (5-year interval), and ethnicity (white or nonwhite, including black, Hispanic, Asian, and other) in a separate model (model 3), because we hypothesized that a significant proportion of their ability to influence the results would be based on the fact that they are associated with being overweight and obese. We included BMI (lean=<25, overweight=>25 and <30, or obese=≥30) and history of diabetes (yes or no) in the final model (model 4) to test whether these variables acted as partial mediators of the relationship between sleep duration and the incidence of hypertension. The significance of individual coefficients in the Cox proportional hazards models were determined by the 95% confidence limits for hazards ratios (HRs).

We tested for multiplicative interaction between age and duration of sleep with the log likelihood ratio test and found that age acted as an effect modifier between the number of hours of sleep per night and the incidence of hypertension (P<0.05). We then stratified the sample by 10-year age increments and performed Cox proportional hazards analyses with each. The HRs for the incidence of hypertension for sleeping ≥7 hours per night compared with the other sleep categories were similar for subjects who were in their 30s, 40s, and 50s at the time of the 1982–1984 follow-up. We chose to divide the sample into 2 age groups with subjects who, at the time of the 1982–1984 study, were between the ages of 32 and 59 years in one group and subjects who were between the ages of 60 and 86 years in another group. After excluding subjects who were deceased, who did not answer the sleep duration question, who had missing data on any of the covariates, and who had hypertension at or before the 1982–1984 survey, there were 3620 subjects between the ages of 32 and 59 years and 1190 subjects between the ages of 60 and 86 years for the analyses.

The NHANES I included weights to account for the complex sampling design and to allow approximations of the US population. We conducted nonweighted analyses using SAS software24 for 3 reasons. First, our objective was not to provide national estimates but to look at the relationship between sleep duration and the incidence of hypertension. Second, the baseline measures of our study were taken from the 1982–1984 follow-up to the NHANES I, so the weights created for baseline measures taken from the 1971–1974 NHANES I did not account for subjects who were lost to follow-up between the 2 waves. Third, there have been differences of opinion regarding the appropriateness of using the sample weights with the NHANES.25


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Results for the bivariate analyses at baseline are shown in Tables 1 and 2Down. There were significant differences between sleep duration categories and the incidence of hypertension for the total sample of subjects between the ages of 32 and 86 years. The relationships between sleep duration categories and the incidence of hypertension were quite different, however, between the younger subjects between the ages of 32 and 59 years and the older subjects between the ages of 60 and 86 years. For the younger subjects, a higher percentage of those who reported at baseline getting <7 hours of sleep per night were diagnosed with hypertension over the follow-up period than those who reported sleeping 7 to 8 hours per night. For the older subjects, a higher percentage of those who reported getting ≥9 hours of sleep per night were diagnosed with hypertension over the follow-up period than those who reported sleeping 7 to 8 hours per night. Table 2 shows the baseline characteristics of the entire sample according to their sleep duration categories. In comparison to self-reported sleep durations of 7 or 8 hours, sleep durations of ≤5 hours were associated with older age, higher BMI, lower physical activity, lower alcohol consumption, higher pulse rate, diagnosis of diabetes, depression, daytime sleepiness, nonwhite ethnicity, and less than a high school graduate education. Sleep durations of ≥9 hours were associated with older age, lower physical activity, higher alcohol consumption, lower salt intake, higher pulse rate, depression, daytime sleepiness, nonwhite ethnicity, and less than a high school graduate education.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Relationship Between Sleep Duration at Baseline and Diagnosis of Hypertension Over Follow-Up


View this table:
[in this window]
[in a new window]
 
TABLE 2. Baseline Characteristics and Risk Factors for Hypertension by Self-Reported Sleep Duration

Table 3 shows the HRs of being diagnosed with hypertension over the 8- to 10-year follow-up period as computed with Cox proportional hazards models. There were 647 total incident cases of hypertension over this period, 472 of which occurred in subjects between the ages of 32 and 59 years and 175 of which occurred in subjects between the ages of 60 and 86 years. The test of significance for the interaction between age category and sleep duration was significant (P=0.0065). In the unadjusted results (model 1) for the total sample between the ages of 32 and 86, subjects who reported sleeping ≤5 hours per night were significantly more likely (HR, 1.76; 95% CI, 1.37 to 2.56) to have been diagnosed with hypertension over the follow-up period than subjects who reported getting 7 or 8 hours of sleep per night. However, these results varied by age, with younger subjects who slept ≤5 hours per night being over twice as likely (HR, 2.10; 95% CI, 1.58 to 2.79) to be diagnosed with hypertension and older subjects who slept ≥9 hours per night being significantly more likely (HR, 1.54; 95% CI, 1.03 to 2.30) to be diagnosed with hypertension. After adjusting for daytime sleepiness, depression, physical activity, alcohol consumption, salt consumption, smoking, pulse rate, and gender (model 2), those who slept ≤5 hours per night continued to be significantly more likely (HR, 1.51; 95% CI, 1.17 to 1.95) to have been diagnosed with hypertension. The addition of demographic variables that are associated with obesity (education, age, and ethnicity) in model 3 attenuated the relationship. Consistent with our hypothesis that BMI and history of diabetes would act as partial mediators of the relationship between sleep duration and the incidence of hypertension, the addition of these variables in model 4 further attenuated the results. The total sample of subjects who reported getting ≤5 hours of sleep per night continued to be significantly more likely (HR, 1.32; 95% CI, 1.02 to 1.71) to be diagnosed with hypertension after controlling for obesity, history of diabetes, and the other covariates. However, the results differ between the younger and older subjects. Subjects between the ages of 32 and 59 years who reported sleeping ≤5 hours per night were significantly more likely (HR, 1.60; 95% CI, 1.19 to 2.14) to have been diagnosed with hypertension than subjects who reported getting 7 or 8 hours of sleep per night, whereas subjects between the ages of 60 and 86 years who slept ≤5 hours were actually slightly less likely (HR, 0.85; 95% CI, 0.50 to 1.45), although not significantly so, to have been diagnosed with hypertension.


View this table:
[in this window]
[in a new window]
 
TABLE 3. HRs (95% CI) of Hypertension Incidence Over the Follow-Up Period by Sleep Duration at Baseline


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
We observed an association between short self-reported sleep duration and the incident diagnosis of hypertension in a large US sample. Subjects between the ages of 32 and 59 years at baseline who reported averaging ≤5 hours of sleep per night were at an increased risk for developing hypertension over the follow-up period. An association between short sleep duration and hypertension incidence was not found for subjects who were between the ages of 60 and 86 years at baseline. There are a number of factors that may explain the different relationships found between short sleep duration and the incidence of hypertension in the younger and older age groups. First, subjects experiencing hypertension, obesity, and diabetes would be less likely to survive into their later years. Second, advanced age is associated with changes in sleep architecture with increased difficulties in sleep initiation and maintenance.26 Elderly subjects, who are often retired, also have more opportunities to take naps during the day. Third, sleep disordered breathing is associated with hypertension in subjects below the age of 60 years but not in subjects 60 years of age or older.22 Activation of the sympathetic nervous system is an important mechanism that links sleep-disordered breathing to combined systolic and diastolic hypertension, which is common in middle aged hypertensive patients. However, no mechanistic link has been identified between sleep-disordered breathing and isolated systolic hypertension that results from age-dependent loss of arterial compliance and accounts for nearly 60% of hypertension in elderly populations.22 Fourth, short sleep duration has been shown to be more strongly associated with obesity in younger subjects than in older subjects.17,18 Fifth, because the sample size of older subjects was low in comparison to the sample size for younger subjects, the lack of an association between short sleep duration and hypertension incidence in the older subjects could be because of a lack of statistical power and, therefore, could represent a type II error.

The association between short sleep duration and the incidence of hypertension was attenuated by the inclusion in the multivariate models of diabetes, body weight, and covariates highly correlated with body weight, such as education, age, and ethnicity. The effect of short sleep duration on hypertension incidence is, therefore, likely to be partially related to the influence of short sleep duration on body weight, perhaps by influencing leptin, ghrelin, appetite, and insulin sensitivity.

The association between short sleep duration and hypertension incidence continued to be statistically significant after controlling for body weight. Short sleep duration is, therefore, likely to have direct effects on the risk for the incidence of hypertension independent of its influence on body weight. These results are consistent with physiological data from previous studies on the effects of sleep deprivation on normotensive3,4 and hypertensive5 subjects. In 2 of those studies, on days after nights of sleep deprivation, significant increases in blood pressure were accompanied by increases in the urinary excretion of norepinephrine indicative of increased sympathetic nervous system activity.3,5 These findings have led to the hypothesis that the mechanism by which sleep deprivation, a stressful condition, raises blood pressure is by increasing the synthesis of catecholamines through the activation of superior centers.5 In all 3 of the studies on the effects of sleep deprivation on blood pressure, subjects had a regular sleep-wake schedule ({approx}8 hours per night) before their sleep was restricted to 3.6 to 4.5 hours per night. The sleep durations of the subjects in our study were not necessarily restricted from a previously regular sleep-wake schedule, so their experience of short sleep duration was likely to have been qualitatively and physiologically different from those of the subjects in the sleep deprivation studies. We also do not know whether short self-reported sleep durations in the NHANES I were indicative of sleep deprivation or whether they simply represented the normal variability between individuals in required sleep durations.

Habitually short sleep durations could lead to the development and maintenance of hypertension through prolonged exposure to raised 24-hour blood pressure and heart rate, elevated sympathetic nervous system activity, waking physical and psychosocial stressors, and increased salt retention. According to Folkow’s12 hypothesis, extended exposure to these forces could lead to the entrainment of the cardiovascular system to operate at an elevated pressure equilibrium through structural adaptations, such as arterial and left ventricle hypertrophic remodeling.

Chronic short sleep durations could also contribute to hypertension by disrupting circadian rhythmicity and autonomic balance. The central biological clock or suprachiasmatic nucleus (SCN) evolved to synchronize activity and rest to the rising and setting of the sun using hormones and the autonomic nervous system. To generate and organize autonomic rhythms, the SCN requires repeated metabolic cues from light exposure, sleep, activity, and feeding. Dramatic alterations in these parameters in modern industrialized society are theorized to cause the environment sensed by the brain to become metabolically flattened and arrhythmic, disturbing the circadian rhythmicity of blood pressure in susceptible individuals.27 Hypertension is characterized by a disturbance in the circadian rhythmicity of many physiological variables, such as a shifting of the daily blood pressure profile to higher values, an increased prevalence of the nondipping pattern, increased blood pressure variability,11 and disturbances in the diurnal rhythm of cardiac output.28 Hypertensive subjects have been shown to have reductions of >50% in the 3 main neuronal populations of the SCN in comparisons between normal subjects and hypertensive subjects who died of myocardial infarction or brain hemorrhage.29

Short sleep duration could also influence hypertension incidence by making it more difficult to maintain a healthy lifestyle. In results from the National Sleep Foundation 2002 Sleep in America Poll, not getting enough sleep was associated with irritability, impatience, pessimism, and feeling tired and stressed.2 It would seem that these feelings and emotional states would function to lessen one’s resolve and willpower to follow dietary or exercise regimens that would be protective against hypertension.

Whereas the results from this epidemiological study lend support to the hypothesis that short sleep duration could lead to hypertension, other important considerations are whether reverse causation contributed toward this finding or whether some uncontrolled confounder played a part in the results. We cannot rule out the possibility that short sleep duration may be a prodromal symptom of hypertension that predates diagnosis. Sleep-disordered breathing and the related clinical syndrome of sleep apnea have been shown in a prospective study to increase the risk for hypertension incidence,30 so the presence of these disorders could have played a part in the association between short sleep duration and hypertension incidence. The NHANES I follow-up survey did not include questions on sleep disorders, but we would expect that individuals with sleep apnea would be more likely to self-report higher average sleep times, because they are often unaware of their disrupted sleep patterns and require longer sleep durations to compensate for poor sleep quality.

One limitation of this study was the use of self-reported sleep durations as opposed to measured sleep durations. However, good agreement has been found in previous studies between self-reported sleep durations and those obtained through actigraphic monitoring.31,32 The NHANES I also lacked repeated measures of sleep duration, so we were unable to determine how representative the baseline sleep measure was of the sleep durations over the follow-up period. Changes in sleeping patterns over the follow-up period could have weakened the association between sleep duration reported at baseline and subsequent hypertension incidence. However, investigators from the Nurses’ Health Study used a sleep duration question similar to the one used in the NHANES I, and they found good reproducibility of their sleep duration question over 2 years.33 The question used in the Nurses Health Study asked, "How many hours of actual sleep do you get in a 24-hour period?" We also want to keep in mind that short sleep duration does not equal insomnia and that we do not know whether short sleepers chose to sleep these hours.

Another limitation of this study relates to the fact that hypertension frequently goes undiagnosed. In an analysis of data from the third NHANES, >30% of subjects who were found to experience hypertension were unaware of their condition.1 We have no way of knowing whether subjects with short sleep durations were more or less likely than subjects with long sleep durations to seek or receive treatment and, therefore, to be diagnosed with hypertension. Other limitations include possible bias arising from loss to follow-up and missing data on baseline risk variables.

Perspectives
The results from this study suggest that short sleep duration could play a role in the etiology of hypertension in some individuals. Further research is needed to investigate the biological mechanisms that link short sleep duration and high blood pressure. If short sleep duration functions to increase blood pressure, then interventions that increase the amount and improve the quality of sleep could potentially serve as treatments and as primary preventative measures for hypertension. Examples of behavioral interventions include helping patients to modify maladaptive sleep habits and educating them about healthier sleep hygiene practices. Studies exploring the efficacy of sleep interventions for the treatment and prevention of high blood pressure could help clarify the proportion of the hypertension risk attributable to short sleep duration.


*    Acknowledgments
 
Financial support for this study was provided by National Research Service Award 5 T32 MH 013043 by the National Institute of Mental Health to the Psychiatric Epidemiology Research Training Program at Columbia University.

Received October 14, 2005; first decision November 1, 2005; accepted January 22, 2006.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2005; 290: 199–206.

2. National Sleep Foundation. 2002 "Sleep in America" Poll. Washington, DC: National Sleep Foundation; 2002.

3. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension. 1996; 27: 1318–1324.[Abstract/Free Full Text]

4. Lusardi P, Mugellini A, Preti P, Zoppi A, Derosa G, Fogari R. Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects. Am J Hypertens. 1996; 9: 503–505.[CrossRef][Medline] [Order article via Infotrieve]

5. Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: A 24-h study. Am J Hypertens. 1999; 12: 63–68.[Medline] [Order article via Infotrieve]

6. Scheer FA, Van Montgrans GA, van Someren EJ, Mairuhu G, Buijs RM. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension. 2004; 43: 192–197.[Abstract/Free Full Text]

7. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, Hu FB. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003; 163: 205–209.[Abstract/Free Full Text]

8. Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of {alpha} adrenergic blocker, doxazosin: results from the HALT study. Hypertension. 2000; 35: 787–794.[Abstract/Free Full Text]

9. Staessen J, Bulpitt CJ, O’Brien E, Cox J, Fagard R, Stanton A, Thijs L, Van Hulle S, Vyncke G, Amery A. The diurnal blood pressure profile: a population study. Am J Hypertens. 1992; 5: 386–392.[Medline] [Order article via Infotrieve]

10. Pickering TG. The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation. 1990; 81: 700–702.[Free Full Text]

11. Folkow B. Mental stress and its importance for cardiovascular disorders; physiological aspects, "from-mice-to-man." Scand Cardiovasc J. 2001; 35: 163–172.[Medline] [Order article via Infotrieve]

12. Folkow B. "Structural factor" in primary and secondary hypertension. Hypertension. 1990; 16: 89–101.[Medline] [Order article via Infotrieve]

13. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288: 2709–2716.[Abstract/Free Full Text]

14. US Department of Health and Human Services, National Center for Health Statistics. National Health and Nutrition Examination Survey I: Epidemiologic Followup Study, 1982–1984 (computer file). 2nd release. Hyattsville, MD: US Department of Health and Human Services, National Center for Health Services (producer); 1992; Ann Arbor, MI: Inter-university Consortium for Political and Social Research (distributor); 1992.

15. US Department of Health and Human Services, National Center for Health Statistics. National Health and Nutrition Examination Survey I: Epidemiologic Followup Study, 1986 & 1987 (computer file). Hyattsville, MD: US Department of Health and Human Services, National Center for Health Services, producer; 1992. Ann Arbor, MI: Inter-university Consortium for Political and Social Research, distributor; 1992.

16. US Department of Health and Human Services, National Center for Health Statistics. National Health and Nutrition Examination Survey I: Epidemiologic Followup Study, 1992 (computer file). Hyattsville, MD: US Department of Health and Human Services, National Center for Health Services, producer; 1996; Ann Arbor, MI: Inter-university Consortium for Political and Social Research, distributor; 1997.

17. Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, Eich D, Rossler W, Angst J. The association between short sleep duration and obesity in young adults: a 13-year prospective study. SLEEP. 2004; 27: 661–666.[Medline] [Order article via Infotrieve]

18. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield S. Inadequate sleep as a risk factor for obesity: analysis of the NHANES I. SLEEP. 2005; 28: 1265–1272.

19. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003; 26: 380–384.[Abstract/Free Full Text]

20. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief Communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004; 141: 845–850.

21. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999; 354: 1435–1439.[CrossRef][Medline] [Order article via Infotrieve]

22. Haas DC, Foster GL, Nieto J, Redline S, Resnick HE, Robbins JA, Young T, Pickering TG. Age-dependent associations between sleep-disordered breathing and hypertension. Circulation. 2005; 111: 614–621.[Abstract/Free Full Text]

23. Cohen BB, Barbano HE, Cox CS, Feldman JJ, Finucane FF, Kleinman JC, Madans JH. Plan and operation of the NHANES I Epidemiologic Followup Study: 1982–84. Vital Health Stat. 1987; 22: 1–142.

24. SAS Institute Inc. The SAS System for Windows, Version 9.0. Cary, NC: SAS Institute Inc.

25. Ingram DD, Makuc DM. Statistical issues in analyzing the NHANES I Epidemiologic Followup Study. Series 2: data evaluation and methods research. Vital Health Stat. 1994; 121: 1–30.

26. Prinz PN. Age impairments in sleep, metabolic and immune functions. Exp Gerontol. 2004; 39: 1739–1743.[CrossRef][Medline] [Order article via Infotrieve]

27. Kreier F, Yilmaz A, Kalsbeek A, Romijn JA, Sauerwein HP, Fliers E, Buijs RM. Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome. Diabetes. 2003; 52: 2652–2656.[Abstract/Free Full Text]

28. Coca A. Circadian rhythm and blood pressure control: physiological and pathophysiological factors. J Hypertens. 1994; 12: S13–S21.

29. Goncharuk VD, Van Heerikhuize J, Dai JP, Swaab DF, Buijs RM. Neoropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock. J Comp Neurol. 2001; 431: 320–330.[Medline] [Order article via Infotrieve]

30. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000; 342: 1378–1384.[Abstract/Free Full Text]

31. Lockley SW, Skene DJ, Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res. 1999; 8: 175–183.[CrossRef][Medline] [Order article via Infotrieve]

32. Hauri PJ, Wisbey J. Wrist actigraphy in insomnia. SLEEP. 1992; 15: 293–301.[Medline] [Order article via Infotrieve]

33. Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB. A prospective study of sleep duration and mortality risk in women. SLEEP. 2004; 27: 440–444.[Medline] [Order article via Infotrieve]


Find additional patient-related information at:

http://www.americanheart.org/presenter.jhtml?identifier=3039197

Related Article:

Sleep and Hypertension: Burning the Candle at Both Ends Really Is Hazardous to Your Health
Brent M. Egan
Hypertension 2006 47: 816-817. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arch Intern MedHome page
K. L. Knutson, E. Van Cauter, P. J. Rathouz, L. L. Yan, S. B. Hulley, K. Liu, and D. S. Lauderdale
Association Between Sleep and Blood Pressure in Midlife: The CARDIA Sleep Study
Arch Intern Med, June 8, 2009; 169(11): 1055 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. A. J. L. Scheer, M. F. Hilton, C. S. Mantzoros, and S. A. Shea
From the Cover: Adverse metabolic and cardiovascular consequences of circadian misalignment
PNAS, March 17, 2009; 106(11): 4453 - 4458.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. J. Decker, J.-M. S. Lin, H. Tabassum, and W. C. Reeves
Hypersomnolence and Sleep-related Complaints in Metropolitan, Urban, and Rural Georgia
Am. J. Epidemiol., February 15, 2009; 169(4): 435 - 443.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. Cohen, W. J. Doyle, C. M. Alper, D. Janicki-Deverts, and R. B. Turner
Sleep Habits and Susceptibility to the Common Cold
Arch Intern Med, January 12, 2009; 169(1): 62 - 67.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. R. King, K. L. Knutson, P. J. Rathouz, S. Sidney, K. Liu, and D. S. Lauderdale
Short Sleep Duration and Incident Coronary Artery Calcification
JAMA, December 24, 2008; 300(24): 2859 - 2866.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. L. Bliwise
Invited Commentary: Cross-Cultural Influences on Sleep--Broadening the Environmental Landscape
Am. J. Epidemiol., December 15, 2008; 168(12): 1365 - 1366.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. Stranges, J. M. Dorn, M. J. Shipley, N.-B. Kandala, M. Trevisan, M. A. Miller, R. P. Donahue, K. M. Hovey, J. E. Ferrie, M. G. Marmot, et al.
Correlates of Short and Long Sleep Duration: A Cross-Cultural Comparison Between the United Kingdom and the United States: The Whitehall II Study and the Western New York Health Study
Am. J. Epidemiol., December 15, 2008; 168(12): 1353 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Shankar, W.-P. Koh, J.-M. Yuan, H.-P. Lee, and M. C. Yu
Sleep Duration and Coronary Heart Disease Mortality Among Chinese Adults in Singapore: A Population-based Cohort Study
Am. J. Epidemiol., December 15, 2008; 168(12): 1367 - 1373.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J.-C. Chen, R. L. Brunner, H. Ren, S. Wassertheil-Smoller, J. C. Larson, D. W. Levine, M. Allison, M. J. Naughton, and M. L. Stefanick
Sleep Duration and Risk of Ischemic Stroke in Postmenopausal Women * Supplemental Appendix
Stroke, December 1, 2008; 39(12): 3185 - 3192.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. Eguchi, T. G. Pickering, J. E. Schwartz, S. Hoshide, J. Ishikawa, S. Ishikawa, K. Shimada, and K. Kario
Short Sleep Duration as an Independent Predictor of Cardiovascular Events in Japanese Patients With Hypertension
Arch Intern Med, November 10, 2008; 168(20): 2225 - 2231.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. F. van den Berg, H. M. E. Miedema, J. H. M. Tulen, A. K. Neven, A. Hofman, J. C. M. Witteman, and H. Tiemeier
Long Sleep Duration is Associated With Serum Cholesterol in the Elderly: The Rotterdam Study
Psychosom Med, November 1, 2008; 70(9): 1005 - 1011.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. U. Viola, L. M. James, S. N. Archer, and D.-J. Dijk
PER3 polymorphism and cardiac autonomic control: effects of sleep debt and circadian phase
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2156 - H2163.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Levy, J-L. Pepin, C. Arnaud, R. Tamisier, J-C. Borel, M. Dematteis, D. Godin-Ribuot, and C. Ribuot
Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives
Eur. Respir. J., October 1, 2008; 32(4): 1082 - 1095.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Javaheri, A. Storfer-Isser, C. L. Rosen, and S. Redline
Sleep Quality and Elevated Blood Pressure in Adolescents
Circulation, September 2, 2008; 118(10): 1034 - 1040.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
A. J Welton, M. R Vickers, J. Kim, D. Ford, B. A Lawton, A. H MacLennan, S. K Meredith, J. Martin, T. W Meade, and for the WISDOM team
Health related quality of life after combined hormone replacement therapy: randomised controlled trial
BMJ, August 21, 2008; 337(aug21_2): a1190 - a1190.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
H. Duez and B. Staels
The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism
Diabetes and Vascular Disease Research, June 1, 2008; 5(2): 82 - 88.
[Abstract] [PDF]


Home page
JCOHome page
K. P. Parker, D. L. Bliwise, M. Ribeiro, S. R. Jain, C. I. Vena, M. K. Kohles-Baker, A. Rogatko, Z. Xu, and W. B. Harris
Sleep/Wake Patterns of Individuals With Advanced Cancer Measured by Ambulatory Polysomnography
J. Clin. Oncol., May 20, 2008; 26(15): 2464 - 2472.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Williams
The Year in Hypertension
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1803 - 1817.
[Full Text] [PDF]


Home page
Psychosom. Med.Home page
E. J. Mezick, K. A. Matthews, M. Hall, P. J. Strollo Jr, D. J. Buysse, T. W. Kamarck, J. F. Owens, and S. E. Reis
Influence of Race and Socioeconomic Status on Sleep: Pittsburgh SleepSCORE Project
Psychosom Med, May 1, 2008; 70(4): 410 - 416.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Kapa, F. H. Sert Kuniyoshi, and V. K. Somers
Sleep Apnea and Hypertension: Interactions and Implications for Management
Hypertension, March 1, 2008; 51(3): 605 - 608.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. Tasali and M. S. M. Ip
Obstructive Sleep Apnea and Metabolic Syndrome: Alterations in Glucose Metabolism and Inflammation
Proceedings of the ATS, February 15, 2008; 5(2): 207 - 217.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. Stranges, F. P. Cappuccio, N.-B. Kandala, M. A. Miller, F. M. Taggart, M. Kumari, J. E. Ferrie, M. J. Shipley, E. J. Brunner, and M. G. Marmot
Cross-sectional versus Prospective Associations of Sleep Duration with Changes in Relative Weight and Body Fat Distribution: The Whitehall II Study
Am. J. Epidemiol., February 1, 2008; 167(3): 321 - 329.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. T. Lam and L. Yang
Short Duration of Sleep and Unintentional Injuries among Adolescents in China
Am. J. Epidemiol., November 1, 2007; 166(9): 1053 - 1058.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. P. Cappuccio, S. Stranges, N.-B. Kandala, M. A. Miller, F. M. Taggart, M. Kumari, J. E. Ferrie, M. J. Shipley, E. J. Brunner, and M. G. Marmot
Gender-Specific Associations of Short Sleep Duration With Prevalent and Incident Hypertension: The Whitehall II Study
Hypertension, October 1, 2007; 50(4): 693 - 700.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. F. van den Berg, J. H.M. Tulen, A. K. Neven, A. Hofman, H. M.E. Miedema, J. C.M. Witteman, and H. Tiemeier
Sleep Duration and Hypertension Are Not Associated in the Elderly
Hypertension, September 1, 2007; 50(3): 585 - 589.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. F. Muldoon, R. H. Mackey, K. Sutton-Tyrrell, J. D. Flory, B. G. Pollock, and S. B. Manuck
Lower Central Serotonergic Responsivity Is Associated With Preclinical Carotid Artery Atherosclerosis
Stroke, August 1, 2007; 38(8): 2228 - 2233.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. J. Williams, F. B. Hu, S. R. Patel, and C. S. Mantzoros
Sleep Duration and Snoring in Relation to Biomarkers of Cardiovascular Disease Risk Among Women With Type 2 Diabetes
Diabetes Care, May 1, 2007; 30(5): 1233 - 1240.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Sayk, C. Becker, C. Teckentrup, H.-L. Fehm, J. Struck, J. P. Wellhoener, and C. Dodt
To Dip or Not to Dip: On the Physiology of Blood Pressure Decrease During Nocturnal Sleep in Healthy Humans
Hypertension, May 1, 2007; 49(5): 1070 - 1076.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, G. Seravalle, F. Quarti-Trevano, F. Scopelliti, R. Dell'Oro, G. Bolla, and G. Mancia
Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome: Characteristics and Mechanisms
Hypertension, March 1, 2007; 49(3): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. Wolk and V. K. Somers
Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Sleep and the metabolic syndrome
Exp Physiol, January 1, 2007; 92(1): 67 - 78.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. F. Thorn
Comparison of Health Status Between the United States and England.
JAMA, November 15, 2006; 296(19): 2312 - 2312.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
S Taheri
The link between short sleep duration and obesity: we should recommend more sleep to prevent obesity
Arch. Dis. Child., November 1, 2006; 91(11): 881 - 884.
[Full Text] [PDF]


Home page
HypertensionHome page
H. Yang, P. L. Schnall, M. Jauregui, T.-C. Su, and D. Baker
Work Hours and Self-Reported Hypertension Among Working People in California
Hypertension, October 1, 2006; 48(4): 744 - 750.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. C. Zee and F. W. Turek
Sleep and health: everywhere and in both directions.
Arch Intern Med, September 18, 2006; 166(16): 1686 - 1688.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Steptoe, V. Peacey, and J. Wardle
Sleep duration and health in young adults.
Arch Intern Med, September 18, 2006; 166(16): 1689 - 1692.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, May 20, 2006; 332(7551): 1222 - 1222.
[Full Text] [PDF]


Home page
HypertensionHome page
B. M. Egan
Sleep and Hypertension: Burning the Candle at Both Ends Really Is Hazardous to Your Health
Hypertension, May 1, 2006; 47(5): 816 - 817.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/5/833    most recent
01.HYP.0000217362.34748.e0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow patientINFORMation
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gangwisch, J. E.
Right arrow Articles by Malaspina, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gangwisch, J. E.
Right arrow Articles by Malaspina, D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Obesity
Right arrow Other etiology
Right arrow Epidemiology
Right arrowRelated Article